Skip to content
Review

The role of USP38 in cellular stress adaptation: Context-dependent ubiquitin chain editing.

Nov 2026 · Cellular Signalling · pp. 112983 · 0 citations · 88 references
Medicine

Abstract

Ubiquitin-specific protease 38 (USP38) edits ubiquitin chains on specific substrates, generating distinct biological outputs under different stress conditions, and thus functions as a context-dependent ubiquitin chain-editing enzyme. USP38 has recently been implicated in innate immunity, inflammatory transcription, fibrotic remodeling, hypoxic adaptation, lipid metabolism, genome maintenance, and tumor progression. However, available studies are scattered across distinct substrates and disease models, potentially leading to an oversimplified view of USP38 as merely a protein-stabilizing factor. Accordingly, this review integrates the molecular functions of USP38 from substrate and ubiquitin-chain-type-dependent perspectives and proposes that USP38 can be viewed as a context-dependent ubiquitin-chain modifier. By removing or remodeling specific ubiquitin chains, USP38 can alter substrate stability, regulate signaling duration, and reset the threshold of cellular stress responses. USP38 acts on diverse substrates, and distinct USP38- substrate axes can translate chain-type-specific deubiquitination into diverse biological outcomes, including inflammatory and fibrotic responses, hypoxic and metabolic adaptation, ferroptosis-associated vulnerabilities, DNA repair, and therapeutic responses, thereby establishing mechanistic links among these processes. Available evidence indicates that USP38-mediated deubiquitination is determined by the linkage type and modification site removed from a given substrate, with functional outcomes ranging from protein stabilization and altered enzymatic activity to subsequent substrate degradation. This review further integrates substrate engagement and complex recruitment, regulatory modifications of USP38, cell type, and stimulus-dependent interaction dynamics to explain how these molecular changes translate into distinct biological outcomes under diverse stress conditions. We also separate well-validated substrate mechanisms from integrative models that remain to be tested. Therefore, USP38-dependent stress-adaptation networks may create exploitable therapeutic vulnerabilities in specific tumors and chronic inflammatory diseases, although systemic inhibition of USP38 may also impair normal tissue homeostasis. Future studies should advance from validating single substrates to exploring chain typ -resolved ubiquitinomics, mapping stress-conditioned interactomes, and developing biomarker - guided, context-specific therapeutic strategies.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.